Aller au contenu principal

 Articles scientifiques

Reactive stroma and trastuzumab resistance in HER2-positive early breast cancer.

Auteurs : Sonnenblick A, Salmon-Divon M, Salgado R, Dvash E, Pondé N, Zahavi T, Salmon A, Loibl S, Denkert C, Joensuu H, Ameye L, Van den Eynden G, Kellokumpu-Lehtinen PL, Azaria A, Loi S, Michiels S, Richard F, Sotiriou C
Année : 2020
Journal : Int J Cancer

Outcomes based on age in the phase III METEOR trial of cabozantinib versus everolimus in patients with advanced renal cell carcinoma.

Auteurs : Donskov F, Motzer RJ, Voog E, Hovey E, Grüllich C, Nott LM, Cuff K, Gil T, Jensen NV, Chevreau C, Negrier S, Depenbusch R, Bergmann L, Cornelio I, Champsaur A, Escudier B, Pal S, Powles T, Choueiri TK
Année : 2020
Journal : Eur J Cancer
Volume : 126
Pages : 1-10

Trastuzumab emtansine (T-DM1)-associated cardiotoxicity: Pooled analysis in advanced HER2-positive breast cancer.

Auteurs : Pondé N, Amaye L, Lambertini M, Paesmans M, Piccart M, de Azambuja E
Année : 2020
Journal : Eur J Cancer
Volume : 126
Pages : 65-73

Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations.

Auteurs : Curigliano G, Lenihan D, Fradley M, Ganatra S, Barac A, Blaes A, Herrmann J, Porter C, Lyon AR, Lancellotti P, Patel A, DeCara J, Mitchell J, Harrison E, Moslehi J, Witteles R, Calabro MG, Orecchia R, de Azambuja E, Zamorano JL, Krone R, Iakobishvili Z, Carver J, Armenian S, Ky B, Cardinale D, Cipolla CM, Dent S, Jordan K
Année : 2020
Journal : Ann Oncol
Volume : 31
Pages : 171-190

Adjuvant chemotherapy for rectal cancer: Current evidence and recommendations for clinical practice.

Auteurs : Bregni G, Akin Telli T, Camera S, Deleporte A, Moretti L, Bali AM, Liberale G, Holbrechts S, Hendlisz A, Sclafani F
Année : 2020
Journal : Cancer Treat Rev
Volume : 83
Pages : 101948

Palbociclib safety and efficacy beyond Ribociclib-induced liver toxicity in metastatic hormone-receptors positive breast cancer patient.

Auteurs : Farhat F, Tarabaih M, Kanj A, Aoun M, Kattan J, Assi T, Awada A
Année : 2020
Journal : Anticancer Drugs
Volume : 31
Pages : 85-89

On-Target Pharmacodynamic Activity of the PI3K Inhibitor Copanlisib in Paired Biopsies from Patients with Malignant Lymphoma and Advanced Solid Tumors.

Auteurs : Morschhauser F, Machiels JP, Salles G, Rottey S, Rule SAJ, Cunningham D, Peyrade F, Fruchart C, Arkenau HT, Genvresse I, Liu L, Köchert K, Shen K, Kneip C, Peña CE, Grevel J, Zhang J, Cisternas G, Reschke S, Granvil C, Awada A
Année : 2020
Journal : Mol Cancer Ther
Volume : 19
Pages : 468-478

Lucitanib for the Treatment of HR<sup>+</sup>/HER2<sup>-</sup> Metastatic Breast Cancer: Results from the Multicohort Phase II FINESSE Study.

Auteurs : Hui R, Pearson A, Cortes J, Campbell C, Poirot C, Azim HA Jr, Fumagalli D, Lambertini M, Daly F, Arahmani A, Perez-Garcia J, Aftimos P, Bedard PL, Xuereb L, Scheepers ED, Vicente M, Goulioti T, Loibl S, Loi S, Pierrat MJ, Turner NC, Andre F, Curigliano G
Année : 2020
Journal : Clin Cancer Res
Volume : 26
Pages : 354-363

A pooled analysis of the cardiac events in the trastuzumab adjuvant trials.

Auteurs : de Azambuja E, Ponde N, Procter M, Rastogi P, Cecchini RS, Lambertini M, Ballman K, Aspitia AM, Zardavas D, Roca L, Gelber Rd, Piccart-Gebhart M, Suter T
Année : 2020
Journal : Breast Cancer Res Treat
Volume : 179
Pages : 161-171

What is the real impact of estrogen receptor status on the prognosis and treatment of HER2-positive early breast cancer?

Auteurs : Brandão M, Caparica R, Malorni L, Prat A, Carey LA, Piccart-Gebhart M
Année : 2020
Journal : Clin Cancer Res

Extended time interval between diagnosis and surgery does not improve the outcome in patients operated for resection or ablation of breast cancer liver metastases.

Auteurs : Lucidi V, Bohlok A, Liberale G, Bez M, Germanova D, Bouazza F, Demetter P, Larsimont D, Aftimos P, Smoll NR, Donckier V
Année : 2020
Journal : Eur J Surg Oncol
Volume : 46
Pages : 229-234

Post-Mastectomy Radiation Therapy in Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer Patients: Analysis of the HERA Trial.

Auteurs : Abi Jaoude J, de Azambuja E, Makki M, Tamim H, Tfayli A, Geara F, Piccart M, Poortmans P, Zeidan YH
Année : 2020
Journal : Int J Radiat Oncol Biol Phys
Volume : 106
Pages : 503-510

PD-1 and PD-L1 inhibitors in oesophago-gastric cancers.

Auteurs : Akin Telli T, Bregni G, Camera S, Deleporte A, Hendlisz A, Sclafani F
Année : 2020
Journal : Cancer Lett
Volume : 469
Pages : 142-150

International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium.

Auteurs : Coens C, Pe M, Dueck AC, Sloan J, Basch E, Calvert M, Campbell A, Cleeland C, Cocks K, Collette L, Devlin N, Dorme L, Flechtner HH, Gotay C, Griebsch I, Groenvold M, King M, Kluetz PG, Koller M, Malone DC, Martinelli F, Mitchell SA, Musoro JZ, OConnor D, Oliver K, Piault-Louis E, Piccart M, Quinten C, Reijneveld JC, Schürmann C, Smith AW, Soltys KM, Taphoorn MJB, Velikova G, Bottomley A
Année : 2020
Journal : Lancet Oncol
Volume : 21
Pages : e83-e96

Early Detection of Metastatic Prostate Cancer Relapse on 68Ga-PSMA-11 PET/CT in a Patient Still Exhibiting Biochemical Response.

Auteurs : Plouznikoff N, Artigas C, Sideris S, Gil T, Flamen P
Année : 2020
Journal : Clin Nucl Med
Volume : 45
Pages : 81-82

Analysis of inflammatory markers and hormones in old cancer patients: A descriptive study.

Auteurs : De Breucker S, Luce S, Njemini R, Bautmans I, Decoster L, Mets T, Pepersack T
Année : 2020
Journal : Exp Gerontol
Volume : 130
Pages : 110787

The Impact of Thyroid Disorders on Clinical Pregnancy Outcomes in a Real-World Study Setting.

Auteurs : Sitoris G, Veltri F, Kleynen P, Cogan A, Belhomme J, Rozenberg S, Pepersack T, Poppe K
Année : 2020
Journal : Thyroid
Volume : 30
Pages : 106-115

pAKT pathway activation is associated with <i>PIK3CA</i> mutations and good prognosis in luminal breast cancer in contrast to p-mTOR pathway activation.

Auteurs : Sonnenblick A, Venet D, Brohée S, Pondé N, Sotiriou C
Année : 2019
Journal : NPJ Breast Cancer
Volume : 5
Pages : 7

Tumor infiltrating B-cells signal functional humoral immune responses in breast cancer.

Auteurs : Garaud S, Buisseret L, Solinas C, Gu-Trantien C, de Wind A, Van den Eynden G, Naveaux C, Lodewyckx JN, Boisson A, Duvillier H, Craciun L, Ameye L, Veys I, Paesmans M, Larsimont D, Piccart-Gebhart M, Willard-Gallo K
Année : 2019
Journal : JCI Insight
Volume : 5

Prevention, Monitoring, and Management of Cardiac Dysfunction in Patients with Metastatic Breast Cancer.

Auteurs : Curigliano G, de Azambuja E, Lenihan D, Calabrò MG, Cardinale D, Cipolla CM
Année : 2019
Journal : Oncologist
Volume : 24
Pages : e1034-e1043